| JTS2400067 | 注射用重组人凝血因子VIIa | Recombinant Coagulation Factor Ⅶa | Lyophilized | Biological Products | Disposable Import Drug Application | 2024-08-08 | | | | | view |
| JYSZ2400009 | 注射用重组人凝血因子Ⅶa | Recombinant Coagulation Factor Ⅶa | Lyophilized | Biological Products | License Renew | 2024-01-13 | | | | | view |
| JYSZ2400007 | 注射用重组人凝血因子Ⅶa | Recombinant Coagulation Factor Ⅶa | Lyophilized | Biological Products | License Renew | 2024-01-13 | | | | | view |
| JYSZ2400008 | 注射用重组人凝血因子Ⅶa | Recombinant Coagulation Factor Ⅶa | Lyophilized | Biological Products | License Renew | 2024-01-13 | | | | | view |
| CXSS2300097 | 注射用重组人凝血因子VIIa | Recombinant Coagulation Factor Ⅶa | Lyophilized | Biological Products(3.4) | New Drug Application | 2023-12-14 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
| JYSB2300060 | 注射用重组人凝血因子Ⅶa | Recombinant Coagulation Factor Ⅶa | Lyophilized | Biological Products | Supplementary Application | 2023-04-05 | | Novo Nordisk A/S | | | view |
| JYSB2300059 | 注射用重组人凝血因子Ⅶa | Recombinant Coagulation Factor Ⅶa | Lyophilized | Biological Products | Supplementary Application | 2023-04-05 | | Novo Nordisk A/S | | | view |
| JYSB2300061 | 注射用重组人凝血因子Ⅶa | Recombinant Coagulation Factor Ⅶa | Lyophilized | Biological Products | Supplementary Application | 2023-04-05 | | Novo Nordisk A/S | | | view |
| CXSL2200322 | 注射用重组人凝血因子VIIa-Fc融合蛋白 | | Lyophilized | Biological Products(1) | New Drug Application | 2022-07-15 | | Jiangsu Shengsi Biopharmaceutical Co Ltd | | | view |
| CXSL2200321 | 注射用重组人凝血因子VIIa-Fc融合蛋白 | | Lyophilized | Biological Products(1) | New Drug Application | 2022-07-15 | | Jiangsu Shengsi Biopharmaceutical Co Ltd | | | view |
| JYSB2101206 | 注射用重组人凝血因子Ⅶa | Recombinant Coagulation Factor Ⅶa | Lyophilized | Biological Products | Supplementary Application | 2021-12-23 | | Novo Nordisk A/S | | | view |
| JYSB2101207 | 注射用重组人凝血因子Ⅶa | Recombinant Coagulation Factor Ⅶa | Lyophilized | Biological Products | Supplementary Application | 2021-12-23 | | Novo Nordisk A/S | | | view |
| JYSB2101208 | 注射用重组人凝血因子Ⅶa | Recombinant Coagulation Factor Ⅶa | Lyophilized | Biological Products | Supplementary Application | 2021-12-23 | | Novo Nordisk A/S | | | view |
| CXSL2000306 | 注射用重组人凝血因子Ⅶa | Recombinant Coagulation Factor Ⅶa | Lyophilized | Biological Products(2.4) | New Drug Application | 2020-10-28 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | In Review | 2020-10-27 | view |
| JYSB2000199 | 注射用重组人凝血因子Ⅶa | Recombinant Coagulation Factor Ⅶa | Lyophilized | Biological Products | Supplementary Application | 2020-05-20 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Filed | 2020-05-29 | view |
| JYSB2000201 | 注射用重组人凝血因子Ⅶa | Recombinant Coagulation Factor Ⅶa | Lyophilized | Biological Products | Supplementary Application | 2020-05-20 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Filed | 2020-05-29 | view |
| JYSB2000200 | 注射用重组人凝血因子Ⅶa | Recombinant Coagulation Factor Ⅶa | Lyophilized | Biological Products | Supplementary Application | 2020-05-20 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Filed | 2020-05-29 | view |
| JYSB2000125 | 注射用重组人凝血因子VIIa | Recombinant Coagulation Factor Ⅶa | Lyophilized | Biological Products | Supplementary Application | 2020-04-18 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2020-11-24 | view |
| JYSB2000124 | 注射用重组人凝血因子VIIa | Recombinant Coagulation Factor Ⅶa | Lyophilized | Biological Products | Supplementary Application | 2020-04-18 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2020-11-24 | view |
| CXSL2000034 | 注射用重组人凝血因子Ⅶa | Recombinant Coagulation Factor Ⅶa | Lyophilized | Biological Products(10) | New Drug Application | 2020-02-27 | 正大天晴药业集团股份有限公司 | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | In Review | 2020-02-26 | view |
